COGT Stock: Price, Earnings History and SEC Filings
Cogent Biosciences, Inc. (COGT) last traded at $31.02, down 2.94% on the latest session and down 3.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.52 against an analyst estimate of $-0.55, a beat of 5.5%.
$31.02 -2.94%
1 month-3.12%
52-week high$43.73
52-week low$13.78
Volume2.50M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
COGT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.52 | $-0.55 | +5.45% |
| Mar 2026 | May 5, 2026 | $-0.53 | $-0.53 | +0.00% |
| Dec 2025 | Feb 17, 2026 | $-0.55 | $-0.51 | -7.84% |
| Sep 2025 | Nov 7, 2025 | $-0.50 | $-0.54 | +7.41% |
COGT beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for COGT
SEC filing data is not available right now. You can search for COGT on SEC EDGAR.
COGT news
- Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation ConferenceOct 27, 2026 · finance.yahoo.com
- Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?Oct 20, 2026 · finance.yahoo.com
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc. (COGT) is a US-listed public company on Nasdaq.